Working… Menu
Trial record 4 of 116 for:    medullary carcinoma

Prospective Study Evaluating the Medullary Thyroid Cancer Management's Care Using PET F-DOPA in Patients With a High Level of Postoperative Residual Thyrocalcitonin (CMTpostopFDOPA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02856347
Recruitment Status : Recruiting
First Posted : August 4, 2016
Last Update Posted : August 8, 2019
Information provided by (Responsible Party):
Institut Claudius Regaud

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 2021
Estimated Study Completion Date : April 2021